Bio Products Laboratory Ltd – FDA 483, Aug 30, 2022
Bio Products Laboratory Ltd. in Elstree, United Kingdom, was cited for significant deficiencies during an FDA inspection from August 22-30, 2022. The observations primarily concern inadequate investigations into product failures, untimely reporting of biological product deviations, and critical failures in aseptic processing, environmental monitoring, and test method validation. These issues indicate a lack of adherence to established procedures and controls, potentially impacting product quality and patient safety.
ID · 024ec8b0-670d-419e-ba7b-cdf496ac2bf9
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.